APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnosis and Treatment Of Hemorrhoids

Compare research editions
View pricing & licenses

Selected research

Industry Research

Diagnosis and Treatment Of Hemorrhoids Industry Research Report 2026

4 July 2026127 pages

Choose your research edition.

Industry ResearchDiagnosis and Treatment Of Hemorrhoids Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnosis and Treatment Of Hemorrhoids Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Diagnosis and Treatment Of Hemorrhoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnosis and Treatment Of Hemorrhoids Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnosis and Treatment Of Hemorrhoids Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Diagnosis and Treatment Of Hemorrhoids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Diagnosis and Treatment Of Hemorrhoids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Diagnosis and Treatment Of Hemorrhoids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Diagnosis and Treatment Of Hemorrhoids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Diagnosis and Treatment Of Hemorrhoids include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Olympus Corporation, Novartis AG, Johnson & Johnson Services, Inc, GlaxoSmithKline, F. Hoffmann-La Roche Ltd, Cook Medical and CONMED Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Diagnosis and Treatment Of Hemorrhoids market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Diagnosis and Treatment Of Hemorrhoids Market by Company

Teva Pharmaceutical Industries Ltd.

Pfizer Inc.

Olympus Corporation

Novartis AG

Johnson & Johnson Services, Inc

GlaxoSmithKline

F. Hoffmann-La Roche Ltd

Cook Medical

CONMED Corporation

Boston Scientific Corporation

Boehringer Ingelheim GmbH

Bayer AG

AstraZeneca

Abbott Laboratories

Diagnosis and Treatment Of Hemorrhoids Segment by Type

Infrared Coagulator

Cryotherapy Device

Bipolar Probe

Sclerotherapy Injector

Hemorrhoid Laser Probes

Others

Diagnosis and Treatment Of Hemorrhoids Segment by Application

Hospital and Clinics

Homecare

Others

Diagnosis and Treatment Of Hemorrhoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnosis and Treatment Of Hemorrhoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnosis and Treatment Of Hemorrhoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnosis and Treatment Of Hemorrhoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Diagnosis and Treatment Of Hemorrhoids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Diagnosis and Treatment Of Hemorrhoids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Diagnosis and Treatment Of Hemorrhoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Diagnosis and Treatment Of Hemorrhoids Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Diagnosis and Treatment Of Hemorrhoids Sales (k units) of Manufacturers (2021-2026) Table 7. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Manufacturers (2021-2026) Table 8. Global Diagnosis and Treatment Of Hemorrhoids Revenue of Manufacturers (2021-2026) Table 9. Global Diagnosis and Treatment Of Hemorrhoids Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Diagnosis and Treatment Of Hemorrhoids Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Diagnosis and Treatment Of Hemorrhoids Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Diagnosis and Treatment Of Hemorrhoids, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Diagnosis and Treatment Of Hemorrhoids, Product Type & Application Table 14. Global Diagnosis and Treatment Of Hemorrhoids Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Diagnosis and Treatment Of Hemorrhoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Industries Ltd. Company Information Table 19. Teva Pharmaceutical Industries Ltd. Business Overview Table 20. Teva Pharmaceutical Industries Ltd. Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Industries Ltd. Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 22. Teva Pharmaceutical Industries Ltd. Recent Developments Table 23. Pfizer Inc. Company Information Table 24. Pfizer Inc. Business Overview Table 25. Pfizer Inc. Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Pfizer Inc. Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 27. Pfizer Inc. Recent Developments Table 28. Olympus Corporation Company Information Table 29. Olympus Corporation Business Overview Table 30. Olympus Corporation Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Olympus Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 32. Olympus Corporation Recent Developments Table 33. Novartis AG Company Information Table 34. Novartis AG Business Overview Table 35. Novartis AG Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Novartis AG Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 37. Novartis AG Recent Developments Table 38. Johnson & Johnson Services, Inc Company Information Table 39. Johnson & Johnson Services, Inc Business Overview Table 40. Johnson & Johnson Services, Inc Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Johnson & Johnson Services, Inc Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 42. Johnson & Johnson Services, Inc Recent Developments Table 43. GlaxoSmithKline Company Information Table 44. GlaxoSmithKline Business Overview Table 45. GlaxoSmithKline Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. GlaxoSmithKline Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 47. GlaxoSmithKline Recent Developments Table 48. F. Hoffmann-La Roche Ltd Company Information Table 49. F. Hoffmann-La Roche Ltd Business Overview Table 50. F. Hoffmann-La Roche Ltd Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. F. Hoffmann-La Roche Ltd Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 52. F. Hoffmann-La Roche Ltd Recent Developments Table 53. Cook Medical Company Information Table 54. Cook Medical Business Overview Table 55. Cook Medical Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Cook Medical Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 57. Cook Medical Recent Developments Table 58. CONMED Corporation Company Information Table 59. CONMED Corporation Business Overview Table 60. CONMED Corporation Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. CONMED Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 62. CONMED Corporation Recent Developments Table 63. Boston Scientific Corporation Company Information Table 64. Boston Scientific Corporation Business Overview Table 65. Boston Scientific Corporation Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Boston Scientific Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 67. Boston Scientific Corporation Recent Developments Table 68. Boehringer Ingelheim GmbH Company Information Table 69. Boehringer Ingelheim GmbH Business Overview Table 70. Boehringer Ingelheim GmbH Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim GmbH Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 72. Boehringer Ingelheim GmbH Recent Developments Table 73. Bayer AG Company Information Table 74. Bayer AG Business Overview Table 75. Bayer AG Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Bayer AG Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 77. Bayer AG Recent Developments Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. AstraZeneca Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 82. AstraZeneca Recent Developments Table 83. Abbott Laboratories Company Information Table 84. Abbott Laboratories Business Overview Table 85. Abbott Laboratories Diagnosis and Treatment Of Hemorrhoids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Abbott Laboratories Diagnosis and Treatment Of Hemorrhoids Product Portfolio Table 87. Abbott Laboratories Recent Developments Table 88. Global Diagnosis and Treatment Of Hemorrhoids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Diagnosis and Treatment Of Hemorrhoids Sales by Region (2021-2026) & (k units) Table 90. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Region (2021-2026) Table 91. Global Diagnosis and Treatment Of Hemorrhoids Sales by Region (2027-2032) & (k units) Table 92. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Region (2027-2032) Table 93. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Region (2021-2026) Table 95. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Region (2027-2032) Table 97. North America Diagnosis and Treatment Of Hemorrhoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2026) & (k units) Table 99. North America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2027-2032) & (k units) Table 100. North America Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Diagnosis and Treatment Of Hemorrhoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2026) & (k units) Table 104. Europe Diagnosis and Treatment Of Hemorrhoids Sales by Country (2027-2032) & (k units) Table 105. Europe Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Diagnosis and Treatment Of Hemorrhoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2026) & (k units) Table 114. South America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2027-2032) & (k units) Table 115. South America Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2021-2026) & (k units) Table 123. Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2027-2032) & (k units) Table 124. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Type (2021-2026) Table 125. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Type (2027-2032) Table 126. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Type (2021-2026) Table 129. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Type (2027-2032) Table 130. Global Diagnosis and Treatment Of Hemorrhoids Price by Type (2021-2026) & (USD/unit) Table 131. Global Diagnosis and Treatment Of Hemorrhoids Price by Type (2027-2032) & (USD/unit) Table 132. Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2021-2026) & (k units) Table 133. Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2027-2032) & (k units) Table 134. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Application (2021-2026) Table 135. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Application (2027-2032) Table 136. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Application (2021-2026) Table 139. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Application (2027-2032) Table 140. Global Diagnosis and Treatment Of Hemorrhoids Price by Application (2021-2026) & (USD/unit) Table 141. Global Diagnosis and Treatment Of Hemorrhoids Price by Application (2027-2032) & (USD/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Diagnosis and Treatment Of Hemorrhoids Distributors List Table 145. Diagnosis and Treatment Of Hemorrhoids Customers List Table 146. Diagnosis and Treatment Of Hemorrhoids Industry Trends Table 147. Diagnosis and Treatment Of Hemorrhoids Industry Drivers Table 148. Diagnosis and Treatment Of Hemorrhoids Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Diagnosis and Treatment Of Hemorrhoids Product Image Figure 5. Global Diagnosis and Treatment Of Hemorrhoids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Diagnosis and Treatment Of Hemorrhoids Market Size (2021-2032) & (US$ Million) Figure 7. Global Diagnosis and Treatment Of Hemorrhoids Sales (2021-2032) & (k units) Figure 8. Global Diagnosis and Treatment Of Hemorrhoids Average Price (USD/unit) & (2021-2032) Figure 9. Infrared Coagulator Product Image Figure 10. Cryotherapy Device Product Image Figure 11. Bipolar Probe Product Image Figure 12. Sclerotherapy Injector Product Image Figure 13. Hemorrhoid Laser Probes Product Image Figure 14. Others Product Image Figure 15. Hospital and Clinics Product Image Figure 16. Homecare Product Image Figure 17. Others Product Image Figure 18. Global Diagnosis and Treatment Of Hemorrhoids Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Diagnosis and Treatment Of Hemorrhoids, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Diagnosis and Treatment Of Hemorrhoids Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Diagnosis and Treatment Of Hemorrhoids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Diagnosis and Treatment Of Hemorrhoids Sales by Region in 2025 Figure 24. Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region in 2025 Figure 25. North America Diagnosis and Treatment Of Hemorrhoids Market Size by Country in 2025 Figure 26. North America Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Country (2021-2032) Figure 27. North America Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Country (2021-2032) Figure 28. United States Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Diagnosis and Treatment Of Hemorrhoids Market Size by Country in 2025 Figure 32. Europe Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Country (2021-2032) Figure 33. Europe Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Country (2021-2032) Figure 34. Germany Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Market Size by Country in 2025 Figure 45. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Country (2021-2032) Figure 47. China Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Diagnosis and Treatment Of Hemorrhoids Market Size by Country in 2025 Figure 56. South America Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Country (2021-2032) Figure 57. South America Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Country (2021-2032) Figure 58. Brazil Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Market Size by Country in 2025 Figure 62. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Country (2021-2032) Figure 64. Egypt Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Diagnosis and Treatment Of Hemorrhoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Type (2021-2032) Figure 70. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Type (2021-2032) Figure 71. Global Diagnosis and Treatment Of Hemorrhoids Price (USD/unit) by Type (2021-2032) Figure 72. Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Application (2021-2032) Figure 73. Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Application (2021-2032) Figure 74. Global Diagnosis and Treatment Of Hemorrhoids Price (USD/unit) by Application (2021-2032) Figure 75. Diagnosis and Treatment Of Hemorrhoids Value Chain Figure 76. Diagnosis and Treatment Of Hemorrhoids Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Diagnosis and Treatment Of Hemorrhoids Industry Opportunities and Challenges

Scope & coverage.

Types
  • Infrared Coagulator
  • Cryotherapy Device
  • Bipolar Probe
  • Sclerotherapy Injector
  • Hemorrhoid Laser Probes
  • Others
Applications
  • Hospital and Clinics
  • Homecare
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Olympus Corporation
  • Novartis AG
  • Johnson & Johnson Services, Inc
  • GlaxoSmithKline
  • F. Hoffmann-La Roche Ltd
  • Cook Medical
  • CONMED Corporation
  • Boston Scientific Corporation
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • AstraZeneca
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Diagnosis and Treatment Of Hemorrhoids Market Size (2021-2032)
  4. 2.2.2 Global Diagnosis and Treatment Of Hemorrhoids Sales (2021-2032)
  5. 2.2.3 Global Diagnosis and Treatment Of Hemorrhoids Market Average Price (2021-2032)
  6. 2.3 Diagnosis and Treatment Of Hemorrhoids by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Infrared Coagulator
  9. 2.3.3 Cryotherapy Device
  10. 2.3.4 Bipolar Probe
  11. 2.3.5 Sclerotherapy Injector
  12. 2.3.6 Hemorrhoid Laser Probes
  13. 2.3.7 Others
  14. 2.4 Diagnosis and Treatment Of Hemorrhoids by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Hospital and Clinics
  17. 2.4.3 Homecare
  18. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Diagnosis and Treatment Of Hemorrhoids Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Diagnosis and Treatment Of Hemorrhoids Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Diagnosis and Treatment Of Hemorrhoids Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Diagnosis and Treatment Of Hemorrhoids Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Diagnosis and Treatment Of Hemorrhoids, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Diagnosis and Treatment Of Hemorrhoids, Product Type & Application
  8. 3.8 Global Manufacturers of Diagnosis and Treatment Of Hemorrhoids, Established Date
  9. 3.9 Global Diagnosis and Treatment Of Hemorrhoids Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical Industries Ltd.
  2. 4.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 4.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 4.1.3 Teva Pharmaceutical Industries Ltd. Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Industries Ltd. Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 4.2 Pfizer Inc.
  8. 4.2.1 Pfizer Inc. Company Information
  9. 4.2.2 Pfizer Inc. Business Overview
  10. 4.2.3 Pfizer Inc. Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Pfizer Inc. Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  12. 4.2.5 Pfizer Inc. Recent Developments
  13. 4.3 Olympus Corporation
  14. 4.3.1 Olympus Corporation Company Information
  15. 4.3.2 Olympus Corporation Business Overview
  16. 4.3.3 Olympus Corporation Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Olympus Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  18. 4.3.5 Olympus Corporation Recent Developments
  19. 4.4 Novartis AG
  20. 4.4.1 Novartis AG Company Information
  21. 4.4.2 Novartis AG Business Overview
  22. 4.4.3 Novartis AG Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis AG Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  24. 4.4.5 Novartis AG Recent Developments
  25. 4.5 Johnson & Johnson Services, Inc
  26. 4.5.1 Johnson & Johnson Services, Inc Company Information
  27. 4.5.2 Johnson & Johnson Services, Inc Business Overview
  28. 4.5.3 Johnson & Johnson Services, Inc Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Johnson & Johnson Services, Inc Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  30. 4.5.5 Johnson & Johnson Services, Inc Recent Developments
  31. 4.6 GlaxoSmithKline
  32. 4.6.1 GlaxoSmithKline Company Information
  33. 4.6.2 GlaxoSmithKline Business Overview
  34. 4.6.3 GlaxoSmithKline Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GlaxoSmithKline Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  36. 4.6.5 GlaxoSmithKline Recent Developments
  37. 4.7 F. Hoffmann-La Roche Ltd
  38. 4.7.1 F. Hoffmann-La Roche Ltd Company Information
  39. 4.7.2 F. Hoffmann-La Roche Ltd Business Overview
  40. 4.7.3 F. Hoffmann-La Roche Ltd Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 F. Hoffmann-La Roche Ltd Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  42. 4.7.5 F. Hoffmann-La Roche Ltd Recent Developments
  43. 4.8 Cook Medical
  44. 4.8.1 Cook Medical Company Information
  45. 4.8.2 Cook Medical Business Overview
  46. 4.8.3 Cook Medical Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Cook Medical Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  48. 4.8.5 Cook Medical Recent Developments
  49. 4.9 CONMED Corporation
  50. 4.9.1 CONMED Corporation Company Information
  51. 4.9.2 CONMED Corporation Business Overview
  52. 4.9.3 CONMED Corporation Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 CONMED Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  54. 4.9.5 CONMED Corporation Recent Developments
  55. 4.10 Boston Scientific Corporation
  56. 4.10.1 Boston Scientific Corporation Company Information
  57. 4.10.2 Boston Scientific Corporation Business Overview
  58. 4.10.3 Boston Scientific Corporation Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Boston Scientific Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  60. 4.10.5 Boston Scientific Corporation Recent Developments
  61. 4.11 Boehringer Ingelheim GmbH
  62. 4.11.1 Boehringer Ingelheim GmbH Company Information
  63. 4.11.2 Boehringer Ingelheim GmbH Business Overview
  64. 4.11.3 Boehringer Ingelheim GmbH Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Boehringer Ingelheim GmbH Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  66. 4.11.5 Boehringer Ingelheim GmbH Recent Developments
  67. 4.12 Bayer AG
  68. 4.12.1 Bayer AG Company Information
  69. 4.12.2 Bayer AG Business Overview
  70. 4.12.3 Bayer AG Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Bayer AG Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  72. 4.12.5 Bayer AG Recent Developments
  73. 4.13 AstraZeneca
  74. 4.13.1 AstraZeneca Company Information
  75. 4.13.2 AstraZeneca Business Overview
  76. 4.13.3 AstraZeneca Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 AstraZeneca Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  78. 4.13.5 AstraZeneca Recent Developments
  79. 4.14 Abbott Laboratories
  80. 4.14.1 Abbott Laboratories Company Information
  81. 4.14.2 Abbott Laboratories Business Overview
  82. 4.14.3 Abbott Laboratories Diagnosis and Treatment Of Hemorrhoids Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Abbott Laboratories Diagnosis and Treatment Of Hemorrhoids Product Portfolio
  84. 4.14.5 Abbott Laboratories Recent Developments
5 Global Diagnosis and Treatment Of Hemorrhoids Market Scenario by Region
  1. 5.1 Global Diagnosis and Treatment Of Hemorrhoids Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region: 2021-2032
  3. 5.2.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region: 2021-2026
  4. 5.2.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region: 2027-2032
  5. 5.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region: 2021-2032
  6. 5.3.1 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region: 2021-2026
  7. 5.3.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region: 2027-2032
  8. 5.4 North America Diagnosis and Treatment Of Hemorrhoids Market Facts & Figures by Country
  9. 5.4.1 North America Diagnosis and Treatment Of Hemorrhoids Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
  11. 5.4.3 North America Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Diagnosis and Treatment Of Hemorrhoids Market Facts & Figures by Country
  16. 5.5.1 Europe Diagnosis and Treatment Of Hemorrhoids Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
  18. 5.5.3 Europe Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Diagnosis and Treatment Of Hemorrhoids Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Diagnosis and Treatment Of Hemorrhoids Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Diagnosis and Treatment Of Hemorrhoids Market Facts & Figures by Country
  41. 5.7.1 South America Diagnosis and Treatment Of Hemorrhoids Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
  43. 5.7.3 South America Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2021-2032)
  2. 6.1.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Type (2021-2032)
  4. 6.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Type (2021-2032)
  5. 6.2.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Diagnosis and Treatment Of Hemorrhoids Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2021-2032)
  2. 7.1.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Application (2021-2032)
  4. 7.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Application (2021-2032)
  5. 7.2.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Diagnosis and Treatment Of Hemorrhoids Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Diagnosis and Treatment Of Hemorrhoids Value Chain Analysis
  2. 8.1.1 Diagnosis and Treatment Of Hemorrhoids Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Diagnosis and Treatment Of Hemorrhoids Production Mode & Process
  5. 8.2 Diagnosis and Treatment Of Hemorrhoids Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Diagnosis and Treatment Of Hemorrhoids Distributors
  8. 8.2.3 Diagnosis and Treatment Of Hemorrhoids Customers
9 Global Diagnosis and Treatment Of Hemorrhoids Analyzing Market Dynamics
  1. 9.1 Diagnosis and Treatment Of Hemorrhoids Industry Trends
  2. 9.2 Diagnosis and Treatment Of Hemorrhoids Industry Drivers
  3. 9.3 Diagnosis and Treatment Of Hemorrhoids Industry Opportunities and Challenges
  4. 9.4 Diagnosis and Treatment Of Hemorrhoids Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst